BioCentury | Nov 8, 2019
Preclinical News

Nov. 7 Preclinical Quick Takes: NIH drafts policy requiring more data sharing; plus Unum, Mission-BioLegend, DCprime and more

...on the Phase I ATTCK-20-2 trial of ACTR087 monotherapy for non-Hodgkin lymphoma in July. Mission, BioLegend...
...to roll out DNA, protein analysis from single cells Mission Bio Inc. is collaborating with BioLegend Inc....
...Along with detecting single nucleotide variants and copy number variations, the Tapestri panels will use BioLegend’s...
BioCentury | Mar 19, 2015
Targets & Mechanisms

Untangling α-synuclein

...the University of Göttingen, includes researchers from Bristol-Myers Squibb Co. , Biogen Idec Inc. , BioLegend Inc....
...team identifies a species that is more prevalent, her group will develop an assay at BioLegend Inc....
..."That assay would then be available through MJFF to the wider research community," said Dave. BioLegend...
Items per page:
1 - 2 of 2
BioCentury | Nov 8, 2019
Preclinical News

Nov. 7 Preclinical Quick Takes: NIH drafts policy requiring more data sharing; plus Unum, Mission-BioLegend, DCprime and more

...on the Phase I ATTCK-20-2 trial of ACTR087 monotherapy for non-Hodgkin lymphoma in July. Mission, BioLegend...
...to roll out DNA, protein analysis from single cells Mission Bio Inc. is collaborating with BioLegend Inc....
...Along with detecting single nucleotide variants and copy number variations, the Tapestri panels will use BioLegend’s...
BioCentury | Mar 19, 2015
Targets & Mechanisms

Untangling α-synuclein

...the University of Göttingen, includes researchers from Bristol-Myers Squibb Co. , Biogen Idec Inc. , BioLegend Inc....
...team identifies a species that is more prevalent, her group will develop an assay at BioLegend Inc....
..."That assay would then be available through MJFF to the wider research community," said Dave. BioLegend...
Items per page:
1 - 2 of 2